A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx
DeciBio delivered a virtual final presentation that covered an in depth quantitative market analysis (e.g., landscape today, key trends, and expected future growth)
Quantitative assessment included:
6 weeks
U.S.
Pharma & Biotech
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy